z-logo
open-access-imgOpen Access
Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer
Author(s) -
Sumanpreet Kaur,
Rajasri Bhattacharyya,
Dibyajyoti Banerjee,
Jaya Shukla
Publication year - 2019
Publication title -
indian journal of clinical biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.392
H-Index - 42
ISSN - 0970-1915
DOI - 10.1007/s12291-019-00863-8
Subject(s) - trastuzumab , breast cancer , context (archaeology) , in silico , oncology , medicine , cancer , pharmacology , chemistry , biology , biochemistry , gene , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom